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Background: Cancer has become a global health problem. China still suffers continuous increasing cancer
mortality. To study the trend of cancer mortality in rural China, this paper established an Age-Period-Cohort model
to discuss the age effect, period effect and cohort effect on cancer mortality in rural China.
Methods: The data were collected from the “China Health Statistical Yearbook” from 1990 to 2010. Collected data
were analyzed by Age-Period-Cohort model and Intrinsic Estimation method.
Results: The age effect on the total cancer mortality represented a V trend. Compared with Group 0–4, Group 5–9
showed 71.87% lower cancer mortality risk. Compared with Group 5–9, Group 75–79 showed 38 times higher
cancer mortality risk. The period effect on the total cancer mortality risk weakened firstly but then increased. It
increased by 35.70% from 1990 to 2010, showing an annual average growth of 1.79%. The cohort effect on the
total cancer mortality risk weakened by totally 84.94% from 1906–1910 to 2005–2010. Three “deterioration periods”
and three “improvement periods” were witnessed during this period. The malignant cancer mortality varied similarly
with the total cancer mortality, while benign cancer mortality and other cancer mortality represented different
variation laws.
Conclusions: Although the total cancer mortality risk is increasing at an accelerated rate, cancer mortality risk
in recent born year is decreasing, indicating very important impact of social change on the cancer mortality in
rural China.Introduction
Generally, cancer mortality is increasing continuously,
and becomes the second leading cause of death in devel-
oped countries and third leading cause of death in devel-
oping countries [1]. It was estimated that there were
12.7 millions of new cancer cases and 7.6 millions of
cancer deaths around the world in 2008. Among them,
56% new cases and 63% deaths were contributed by
underdeveloped regions [2]. With the continuous in-
crease and aging of world population, cancer mortality is
expected to further increase [2,3]. Although cancer be-
came a disease burden in developed regions firstly,
cancer mortality in other places is expected to exceed
that in developed regions in the future [4]. Cancer mor-
tality in some underdeveloped or economic transitional
regions such as Africa and Asia is still increasing [5]. It
is estimated that in 2020, developing countries and* Correspondence: yuchua@163.com
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stated.emerging industrialized countries will suffer the quickest
growth of cancer mortality, while some western coun-
tries will decrease cancer mortality as they adopted
tobacco resistance and healthy lifestyle [1].
As a large population country in the world, China ac-
counts for 1/4 of the total cancer deaths with quick in-
creasing cancer mortality. This will absolutely bring
great impact on the global variation trend of cancer and
cancer burden, thus deserving deeper studies [6,7]. Some
research compared the cancer mortality in developed
countries and developing countries, reporting that can-
cer mortality in China has both characteristics of devel-
oped countries and developing countries [8]. According
to the “2012 Annual Report of Cancer in China”, inci-
dence rate, mortality risk and younger patient propor-
tion of cancer all increased during the past two decades.
It is estimated an annual increase of 3.12 millions of
cancer cases and a daily increase of 8,850 cancer cases
in China. Furthermore, there are 6 persons diagnosed
as malignant cancer per minute. Furthermore, 22% oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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predicted that the malignant cancer incidence and mor-
tality in China will continue to increase in the next two
decades [11]. Malignant cancer not only has become a
serious disease that threatens people’s survival and social
development in China, but also brings heavy burden for
both families and the society [12].
With the increasing cancer burden in China, the dif-
ferent trend of cancer mortality in China has attracted
increasing attentions from researchers. There are re-
searches on selected cancer mortality for limited popula-
tions and time periods (e.g. lung cancer, nasopharyngeal
cancer, stomach cancer, esophagus cancer, liver cancer,
breast cancer and cervical cancer), and also researches on
the cancer mortality in special regions (e.g. Shandong,
Henan, Hebei, Taiwan and Hong Kong) [13-21]. Further-
more, there are three major researches focusing on the na-
tional cancer mortality [22,23]. However, they failed to give
the cohort effect analysis or the whole cancer variation
trend analysis in a long history perspective. To make a
national plan of time-sensitive and purposeful cancer pre-
vention planning as well as effect evaluation of existing
measures, a latest comprehensive evaluation on cancer
mortality is needed [24].
In this paper, the age effect, period effect and cohort
effect were discussed by establishing an APC model. A
statistical analysis on the cancer mortality of 0–84 year
old from1990 to 2010 was carried out in rural China, in-
volving total cancer mortality, malignant cancer mortal-
ity, benign cancer mortality and other cancer mortality.
The period effect (since 1990) and cohort effect (since
1906) on cancer mortality were explored on the basis of
age effect. Key attentions were paid to the analysis of co-
hort effect, including level and variation rate of cohort
effect. The systematic analysis on the research results
not only lays foundation for discussing the relationship
between social development and cancer burden, but also
can assist to explore the influence factors of cancer inci-
dence and development. The research results can be
served as scientific references for making national cancer
prevention.
Methods
Data source and processing
Data were collected from the “China Health Statistical
Yearbook” of 1990, 1995, 2000, 2005 and 2010. The
mortality statistics of these five years enjoy high reliabil-
ity and authority. Data of 2000 is not available, mean
scores of 1999 and 2001 are used to substitute for it.
Furthermore, mortality statistics were based on an age
group of five years old. The APC model requires death
statistics per five years. Among the involved data, age-
specific cancer mortality took the cancer mortality in
age statistics of the year/census population of theyear × 1/100,000 as the proportionality coefficient.
Originally, mortality statistics about 0 year old and
1–4 years old were independent from each other. However,
these two age groups were integrated in this paper for Age-
Period-Cohort (APC) model analysis (5-year a group). The
last population census before 1990 was carried out in 1982,
which can’t be input in APC model.
Only data from Group 0–4 to Group 80–84 were applied.
Data above 85 years old in the “China Health Statistical
Yearbook” were integrated into one age group which also
involving those above 89 years old. Therefore, this age
group couldn’t be used for APC model analysis.
Statistical analysis of APC model
Since APC model can explore age effect, period effect
and cohort effect from the observed age-specific death
data, it is widely applied in sociological, demographical
and epidemiologic studies [25]. In this paper, the latest
Intrinsic Estimation (IE) algorithm in the APC model
that had been confirmed as estimability, non-bias, valid-
ity and asymptotic was applied [25]. Currently, the IE al-
gorithm has been used to study human mortality and
disease incidence in developed countries and regions.
The APC model for statistical analysis was established
on the basis of cancer mortality data in rural China from
the “China Health Statistical Yearbook” of 1990, 1995,
2000, 2005 and 2010. The earliest cohort in our APC
model was Group 80–84. They were born during 1906–
1910. Therefore, the established APC model can esti-
mate the cancer mortality of people born from 1906 to
2010.
In this paper, data were analyzed through the apc_ie
that was specially designed for IE algorithm of APC
model [25]. The data-model fitting degree was evaluated
by fitting deviance, AIC and BIC. The standard error
(SE) of every model coefficient was calculated. Addition-
ally, odds ratio was calculated from estimated model pa-
rameters, which represented the mortality level. The
mortality change was expressed by the difference of odds
ratio before and after the birth cohort.
Results
The age, period and cohort-based variation of cancer
mortality
Age-based variation of cancer mortality
The variation of cancer mortality in rural China in 1990,
1995, 2000, 2005 and 2010 with age was shown in
Figure 1. Firstly, the total cancer mortality risk increased
with age. Before 20 years old, the cancer mortality risk
was lower without obvious change (Figure 1). Combined
with the “China Health Statistical Yearbook”, it is easy to
find that Group 0–4 suffers the highest cancer mortality
risk, which fluctuated with ages. The cancer mortality
risk increased at a steady speed after 20 years old. Before
Figure 1 Age-specific cancer mortality in different years (per 100,000 persons).
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as growing elder. However, after 75 years old, the in-
crease of cancer mortality risk in 1990 and 1995 slowed
down and the slope of corresponding broken line de-
creased in Group 70–74 (Figure 1). The cancer mortality
risk of Group 80–84 decreased in 2000 and 2005,
quicker in 2005. However, the total cancer mortality in
2010 presented a sharp increase from 7.18/100,000 of
Group 20–24 to 1356.30/100,000 of Group 80–84.
Malignant cancer mortality accounts for about 90% of
the total cancer mortality in all years and among all age
groups. This is why malignant cancer mortality varied
similarly with total cancer mortality. The following stat-
istical results, including period effect, cohort effect, APC
model analysis results and change rate of cohort, also
showed similar variation law. Therefore, the malignant
cancer mortality wasn’t analyzed independently to every
result.
Benign cancer mortality was relative lower, peaking
at only (5.30/100,000) of Group 80–84 in 2010. It
decreased from Group 0–9 and then fluctuated gently.
However, it showed a wave growth after 35 years
old and fluctuated more violently in older groups.
Additionally, other cancer mortality was even lower
except for some age groups, such as Group 75–79 in
2010 (6.25/100,000). The benign cancer mortality risk
decreased from Group 0–9 and then its broken linebecame close to the X-axis. However, it increased sig-
nificantly after 35 years old and showed a wave growth
after 65 years old. The most violent fluctuations were
in 2005 and 2010.
Period-based variation of cancer mortality
The cancer mortality variation of different age groups
from 1990 to 2010 was shown in Figures 2 and 3.
Figure 2 showed the cancer mortality of 0–39 years old,
while Figure 3 showed the cancer mortality of 40–
84 years old. Except for Group 5–9 and Group 55–59
that decreasing continuously, the cancer mortality of rest
age groups fluctuated differently. The comparative ana-
lysis on the cancer mortality of age groups in different
years demonstrated that the cancer mortality risk of
Group 80–84 and Group 75–79 increased significantly
during 2005–2010 and 2000–2010 respectively, while
that of rest age groups changed gently. The cancer
mortality risk of Group 80–84 increased by 65.17% from
821.16/100,000 in 2005 to 845.02/100,000 in 2010,
showing an annual average growth of 13.03%. The
cancer mortality risk of Group 75–79 increased by
32.17% from 845.02/100,000 in 2000 to 1116.89/100,000
in 2010, showing an annual average growth of 3.22%.
Viewed from the cancer mortality variation from 1990
to 2010, Group 0–4 increased slightly and Group 75–79
as well as Group 80–84 increased significantly, while the
Figure 2 Cancer mortality (100,000 persons) variation of different age groups during 1990–2010: 0–39 years old.
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ity wasn’t analyzed specially due to its similar variation
law with that of total cancer mortality.
No obvious variation law of benign cancer mortality
was observed in Figures 2 and 3. Different age groups
exhibited different variation laws. However, the benign
cancer mortality fluctuated more violently during 2000–
2010 than that during 1990–2000. The benign cancer
mortality risk showed a V-shaped variation trend from
2000 to 2010, while the benign cancer mortality risk was
close to the X-axis from 1990 to 2000. Other cancer
mortality risk changed gently during 1990–2000 but in-
creased during 2000–2010.Cohort-based variation of cancer mortality
A cohort-based chart of age-specific mortality was
drawn to make an intuitive evaluation of the birth co-
hort effect. The cohort-based variation of age-specific
cancer mortality was shown in Figures 4 and 5. Different
age groups showed different cohort-based variations of
total cancer mortality. Except for Group 5–9 and Group
55–59 that decreasing continuously, the cancer mortality
of all age groups fluctuated with the change of cohort
year. Generally speaking, younger groups suffered less
cancer mortality risks than older groups. The cohort-
based variation of different types of cancer mortality will
be discussed in the following text through APC model.APC model analysis results of cancer mortality
Age effect, period effect and cohort effect can be explored
through APC model, thus enabling to study the impact of
independent factors on the variation of cancer mortality.
The APC model analysis results of age-specific cancer
mortality were listed in Table 1.
Age effect
In Table 1 and Figure 6, the coefficient of cancer mortal-
ity estimation showed a V-shaped variation trend with
ages. Group 5–9 has the lowest cancer mortality. This
coefficient decreased by 1.2682 from Group 0–4 to
Group 5–9 and the corresponding mortality risk reduced
by 71.87%. The mortality risk of Group 75–79 was more
than 38 times than that of Group 5–9. From Group 5–9
to Group 75–79, the growth rate of mortality increased
firstly and then decreased, reaching the peak at Group
30–35, 77.45% higher over the previous year. The mor-
tality reduced from Group 75–79 to Group 80–84.
The benign cancer mortality of younger population de-
creased firstly and then increased. The minimum coeffi-
cient of age effect estimation was in Group 20–24.
Other cancer mortality in rural China represented a
wave increase with the growth of age.
Period effect
The period effect on the total cancer mortality was esti-
mated to increase according to Table 1 and Figure 7.
Figure 3 Cancer mortality (100,000 persons) variation of different age groups during 1990–2010: 40–84 years old.
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crease of 0.3053 = [0.2385-(−0.0668)] from 1990 to 2010.
It indicated that the period effect alone increased the
total cancer mortality risk by 35.70% from 1990 to 2010,
showing an annual average growth of 1.79%. The total
cancer mortality risk reduced by 1.24% from 1990 to
1995 and only increased by 4.15% from 1995 to 2005.
However, the total cancer mortality risk increased sig-
nificantly (31.94%) from 2005 to 2010.
The period effect on benign cancer mortality generally
decreased. According to Table 1, the coefficient of esti-
mation increased by 0.0984 from 1995 to 2000 and the
corresponding mortality increased by 10.34%. However,
such coefficient decreased by 0.4649 from 1990 to 2010
and the corresponding mortality risk reduced by 37.18%.
The greatest decrease of mortality was occurred during
1990–1995 and 2005–2010. The coefficient of estimation
of period effect on other cancer mortality changed sig-
nificantly, which increased firstly and then decreased. It
decreased by 0.3972 from 1990 to 1995 and then in-
creased by 2.1975 from 1995 to 2010, showing a growth
of more than eight times.
Cohort effect
The cohort effect on cancer mortality was shown in
Figure 8. The total cancer mortality risk decreased by
84.94% from the birth year of 1906 to 2010. There were
three rises of birth cohort effect from 1906 to 2010. The
first rise was from 1916–1920 to 1926–1930, reachingthe peak with a growth of 0.0802 (odds ratio = 1.0835).
The second rise was from 1981–1985 to 1986–1990 with
a growth of 0.0059 (odds ratio = 1.0059). The third rise
started from 1996–2000 with a growth of 0.4017 (odds
ratio = 1.4944) till 2006–2010.
The coefficient of estimation of birth cohort effect on
benign cancer mortality achieved a great wave growth
from 1906 to 2010. According to Table 1 and Figure 8,
the mortality coefficient of population born during
2006–2010 was 1.0451 higher than that born during
1906–1910 and the corresponding cancer mortality risk
almost doubled. It demonstrated a relative lower mortal-
ity coefficient (−4.5496) of population born during
2001–2005 (Table 1). This was caused by the lower can-
cer mortality risk of population born during 2001–2005
(Group 0–4 and Group 5–9 in 2005). The cohort effect
on other cancer mortality risk fluctuated more violently
compared with that of total cancer mortality. The popu-
lation born during 1906–1910 expressed the highest
cancer mortality risk with a coefficient of 1.6734. Add-
itionally, two obvious low mortality coefficients were ob-
served in population born in 1971–1975 (−1.8890) and
1996–2000 (−1.8511).
Comparison of different estimated effects of APC model
on cancer mortality
To make a more intuitive comparison of age, period
and cohort effects estimated by APC model on differ-
ent cancers, these three effects were converted to be
Figure 5 Cohort-based variation of age-specific cancer mortality (100,000 persons): 40–84 years old.
Figure 4 Cohort-based variation of age-specific cancer mortality (100,000 persons): 0–39 years old.
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Table 1 APC model analysis results of cancer mortality in rural China
Total cancer Malignant cancer Benign cancer Other cancer
APC (SE) APC (SE) APC (SE) APC (SE)
Intercept 4.1765 0.0355 4.1558 0.0364 −0.7551 0.5315 −1.8801 0.4333
Age(year)
0-4 −0.6590 0.1729 −0.7038 0.1791 0.5163 1.1350 0.6330 1.5291
5-9 −1.9272 0.2320 −1.9445 0.2377 −1.1271 1.4011 −1.9687 3.0150
10-14 −1.8556 0.2188 −1.8935 0.2264 −0.8411 1.1985 −0.5159 1.8210
15-19 −1.7353 0.1944 −1.7482 0.1996 −1.2748 1.2196 −0.6843 1.8427
20-24 −1.5254 0.1673 −1.5106 0.1700 −1.5462 1.2851 −1.9324 2.5174
25-29 −1.2398 0.1489 −1.2276 0.1511 −1.4669 1.2144 −1.4154 2.6771
30-34 −0.6662 0.1206 −0.6567 0.1224 −0.7488 0.9665 −0.9775 2.2841
35-39 −0.3162 0.1006 −0.3022 0.1021 −0.8108 0.9190 −0.2744 2.1731
40-44 0.0720 0.0820 0.0851 0.0831 −0.3713 0.7744 −0.3830 1.9106
45-49 0.4089 0.0660 0.4210 0.0668 −0.0609 0.6661 0.2427 1.5079
50-54 0.7334 0.0513 0.7428 0.0518 0.4817 0.5744 0.5105 1.2642
55-59 0.9497 0.0394 0.9590 0.0397 0.6508 0.5482 0.1627 1.0776
60-64 1.2226 0.0325 1.2295 0.0328 0.9617 0.5374 1.0716 0.7773
65-69 1.4060 0.0346 1.4117 0.0351 1.0818 0.6058 1.1048 0.6529
70-74 1.6549 0.0434 1.6587 0.0443 1.2643 0.6944 1.6847 0.6231
75-79 1.7405 0.0563 1.7417 0.0575 1.6493 0.7989 1.5872 0.7320
80-84 1.7367 0.0712 1.7375 0.0726 1.6420 0.9360 1.1546 0.9871
Period(year)
1990 −0.0668 0.0350 −0.0699 0.0356 0.1702 0.3538 −0.5033 0.6949
1995 −0.0793 0.0211 −0.0798 0.0213 −0.0147 0.2571 −0.9005 0.5885
2000 −0.0537 0.0138 −0.0535 0.0139 0.0837 0.2102 −0.3285 0.4570
2005 −0.0387 0.0214 −0.0381 0.0216 0.0555 0.2543 0.4352 0.4313
2010 0.2385 0.0344 0.2414 0.0351 −0.2947 0.3709 1.2970 0.5957
Cohort(year)
1906-1910 0.9928 0.0919 1.0120 0.0937 −0.3894 1.0242 1.6734 1.7152
1911-1915 0.9156 0.0735 0.9312 0.0750 0.4257 0.7101 1.1569 1.3716
1916-1920 0.9029 0.0574 0.9175 0.0586 0.4945 0.5565 0.4461 1.1632
1921-1925 0.9121 0.0427 0.9278 0.0436 −0.0499 0.4729 −0.4297 1.0864
1926-1930 0.9831 0.0298 0.9944 0.0305 0.6500 0.3163 0.6721 0.5993
1931-1935 0.8449 0.0257 0.8549 0.0262 0.1299 0.3769 0.8187 0.5010
1936-1940 0.6825 0.0319 0.6916 0.0324 0.2655 0.4417 −0.1999 0.7101
1941-1945 0.5315 0.0444 0.5348 0.0451 0.6363 0.5188 0.6714 0.8144
1946-1950 0.4604 0.0588 0.4647 0.0597 0.4620 0.6729 −0.2208 1.1755
1951-1955 0.3298 0.0747 0.3309 0.0759 0.4928 0.8198 0.4090 1.3562
1956-1960 −0.0161 0.0933 −0.0164 0.0947 0.3039 0.9907 −0.2930 1.6847
1961-1965 −0.0530 0.1096 −0.0585 0.1115 0.7783 1.0715 −0.3300 1.9534
1966-1970 −0.2125 0.1273 −0.2183 0.1294 0.4482 1.2565 −0.1442 2.1941
1971-1975 −0.5621 0.1517 −0.5684 0.1543 0.3477 1.3530 −1.8890 3.5877
1976-1980 −0.8006 0.1771 −0.8066 0.1802 −0.3217 1.6126 0.0147 2.1560
1981-1985 −0.8455 0.1953 −0.8619 0.1996 0.2432 1.4630 −0.4238 2.6424
1986-1990 −0.8396 0.1730 −0.8873 0.1800 0.3938 1.3209 0.5025 1.6030
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Table 1 APC model analysis results of cancer mortality in rural China (Continued)
1991-1995 −1.0576 0.2095 −1.0736 0.2164 −0.1679 1.5222 −0.2542 1.7865
1996-2000 −1.3019 0.2523 −1.2730 0.2569 −1.2491 2.0321 −1.8511 3.1430
2001-2005 −0.9667 0.2430 −0.9380 0.2476 −4.5496 8.7121 −0.1049 1.8721
2006-2010 −0.9002 0.2714 −0.9577 0.2861 0.6557 1.8177 −0.2243 1.7779
Deviance 95.7702 94.1017 12.1555 7.7004
DF 45 45 45 45
AIC 8.1011 8.0605 2.7343 1.9656
BIC −104.1491 −105.8176 −187.7638 −192.2189
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effects estimated by APC model from the total cancer
mortality and different cancer mortalities were shown
in Figure 9.
The age effect on the total cancer mortality decreased
firstly and then increased, reaching the bottom at Group
5–9. The age effect on all of these three cancer mortal-
ities represented a typical V-shaped trend. However, the
coefficient of estimation of other cancer mortality fluctu-
ated more violently, especially at younger groups. Fur-
thermore, it decreased significantly after 70–74 years
old. The estimation coefficient of benign cancer mortal-
ity also fluctuated at younger groups and increased
continuously after 20–24 years old. The estimationFigure 6 Age effect on cancer mortality in rural China.coefficient of malignant cancer mortality decreased be-
fore nine years old and then increased stably until
79 years old.
The broken line of period effect on the total cancer
mortality basically extended towards the horizontal
direction until the significant increase of estimation
coefficient in 2005. The malignant cancer mortality,
benign cancer mortality and other cancer mortality
had different variation laws. The broken line of malig-
nant cancer mortality changed similarly with that of
total cancer mortality. The coefficient estimation of
benign cancer mortality increased continuously to get
close to the broken line of total cancer mortality dur-
ing 1990–2005, but began to decrease after 2005. The
Figure 7 Period effect on cancer mortality in rural China.
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creased firstly and then increased, especially after
1995.
The cohort effect on the total cancer mortality risk de-
creased generally. However, a great gap of variation law
was observed among the malignant cancer mortality, be-
nign cancer mortality and other cancer mortality. With
similar variation law of the total cancer mortality, the es-
timation coefficient of malignant cancer mortality de-
creased stably with a slight fluctuation. The estimation
coefficient of benign cancer mortality showed a wave
growth and its broken line maintained at the top pos-
ition. However, the estimation coefficient of other cancer
mortality represented a wave decrease and its broken
line was in the bottom, crossing with that of malignant
cancer mortality.Variation velocity analysis of cohort effect
To have a more accurate understanding on the variation
law of cohort effect, we converted the estimated effects
into odds ratio by taking 1906–1910 as reference point.
Next, the odds ratio of the year subtracted the odds ratio
of previous year according to the principle of numerical
differentiation, which shall be positive when mortality
risk increased, negative when mortality risk reduced and0 when mortality risk remained same. If the mortality
risk reduced or increased at a constant speed, the corre-
sponding line in Figure 10 will be parallel to the X-axis.
Larger distance between the line and X-axis represents
quicker variation of mortality risk, while shorter distance
represents slower variation of mortality risk. Similarly, if
the line distances away from the X-axis gradually, the
variation velocity of mortality risk accelerates, otherwise,
decelerates.
It can be seen from Figure 8 that the variation velocity
of cohort effect on both of the total cancer mortality and
different types of cancer mortality fluctuated during
1911–2010. For the total cancer mortality, most parts of
its broken line were above the X-axis (negative). Just as
stated above, the cohort effect decreased generally,
which had three accelerating decreases. The first accelerat-
ing decrease started from 1926–1930 to 1936–1940. The
second accelerating decrease started from 1946–1950 to
1956–1960, accelerated by 0.11 from −0.04 to −0.15. The
third accelerating decrease started from 1961–1965 to
1971–1975, accelerated by 0.08 from −0.01 to −0.09. In
Figure 10, the variation velocity of benign cancer mortality
fluctuated violently without certain law. The variation vel-
ocity of other cancer mortality also fluctuated between
above and below the X-axis, which further indicated the al-
ternation of increase and decrease of cohort effects. The
Figure 8 Cohort effect on cancer mortality in rural China.
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varied in different birth years, thus resulting in no strong
variation law.
Conclusion
The age effect on the total cancer mortality shows a typ-
ical V-shaped variation trend. It decreases by 72% from
Group 0–4 to Group 5–9 and then increases by more
than 38 times until Group 75–79. It achieves the quick-
est increased at Group 30–35. Group 0–4 contributes
high cancer mortality, which is certain related with the
high incidence of childhood leukemia and embryonal
malignant cancers before 5 years old. Viewed from the
period effect during 1990–2010, the total cancer mortal-
ity decreased by 1.24% during 1990–1995 and increased
only by 4.15% during 1995–2005. However, it increased
significantly (32%) during 2005–2010. The Joinpoint
analysis demonstrated that the total cancer mortality
in United States kept stable during 1990–1993 but
achieved an annual decrease of 1.1% during 1993–2002
and an annual decrease of 1.8% during 2002–2005 [26].
It indicates that China still has a long way to go to re-
duce its cancer incidence and mortality.
Viewed from the cohort effect during 1906–2010, the
total cancer mortality decreased generally with four “de-
terioration periods” and three “improvement periods”.This is closely related with China’s social change
in recent one hundred years. The first deterioration
period (from 1916–1920 to 1926–1930) echoed with the
first revolutionary war when suffered continuous wars,
caused great damages to the medical and health services.
Serious environmental destructions caused by wars also
increased the environmental cancer risk. Such destruc-
tions lasted until 1930. The second deterioration period
is from 1956-1960 to 1961-1965, coinciding with the
three years of natural disasters. The third deterioration
period (from 1981–1985 to 1986–1990) coincided with
the reform and opening-up policy in 1978. During this
period, China strived to accelerate economic develop-
ment and industrialization, which brought serious air,
water and soil pollutions, led to environmental cancer
risk. During the fourth deterioration period (from 1996–
2000 to 2006–2010), the progresses of urbanization,
industrialization and globalization caused ecological en-
vironment deterioration, frequent occupational exposure
and dietary structure as well as lifestyles change. These
factors, together with aging of population and smoking,
increased the cancer mortality continuously.
Although the above three “deterioration periods”
attacked people’s health and social economic develop-
ment, China still achieved outstanding fruits in health-
care development in recent one hundred years and
Figure 9 Estimated Age-Period-Cohort effects on cancer mortality from 1990–2010.
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http://www.equityhealthj.com/content/13/1/1cancer prevention since 1950s [27]. Particularly, the total
cancer mortality had three “improvement periods”. The
first improvement period started from 1926–1930 to
1936–1940. This is beginning of medical and public
health service in China. The public health in rural China
achieved outstanding improvements, which facilitated
the effective cancer prevention and increased cancer
survivals [28]. The second improvement period (from
1946–1950 to 1956–1960) was benefited from the re-
habilitation and national economic prosperity after liber-
ation. After the founding of new China, the public health
services implemented in rural in 1930s was maintained,
and the health-center system of counties proposed by the
Department of Health was recovered and re-established
[28]. Furthermore, China’s basic environmental health con-
ditions were improved effectively through “prevention-ori-
ented” measures [29]. On the other hand, China initiated
the cancer prevention since late 1950s. China determined
six cancers (e.g. esophagus cancer and cervical cancer) asFigure 10 Variation velocity of cohort effect on cancer mortality duri
effect, the Y-axis of the statistical chart didn’t include all variation velocitieskey prevented common cancers in 1958. National cervical
cancer survey has been organizing since 1958. In 1959, the
esophagus cancer was studied in four provinces and one
city in North China and corresponding prevention stations
were established [30]. The third improvement period (from
1961–1965 to 1971–1975) was the key period of cancer
prevention in China. During this period, the National
Cancer Prevention and Research Institute were founded;
the first national survey on cause of death was accom-
plished; the distribution law and characteristics of ma-
lignant cancer mortality in China were disclosed. On
this basis, a series of research institutes of cancer high-
incidence areas and cancer prevention were established
and a cancer prevention team was trained. These con-
tributed a great stride of China’s cancer prevention
during this period [27].
Statistical analysis on malignant, benign and other
cancer mortalities as well as the total cancer mortality in
rural China is carried out. The results demonstrate thatng 1911–2010. Note: To clearly represent the variation law of cohort
of benign cancer mortality.
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http://www.equityhealthj.com/content/13/1/1malignant cancer mortality has similar variation law with
the total cancer mortality, while benign and other cancer
mortalities have unique variation features. Since the be-
nign and other cancer mortalities account for less than
10% of the total cancer mortality, they won’t influence
the variation law of the total cancer mortality. Finally,
this paper also has some limitations. It involves neither
gender-specific statistics of cancer mortality nor inde-
pendent analysis of some harmful malignant cancers,
such as lung cancer, liver cancer, stomach cancer,
esophagus cancer, colorectal cancer, etc. However, a deep
analysis on the variation of cohort effect on cancer mor-
tality in rural China since 1906 is carried out in consid-
ering of China’s modern history, development of health
service and cancer prevention. The research results are
beneficial for predicting future trend of cancer mortality
in China, exploring the influence factors of cancer inci-
dence, and providing some references to domestic and
foreign cancer prevention.
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